Is the New Ebola Outbreak Different This Time?

Authored by:

Venkat Rao

Recently, World Health Organization has declared the current Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda a Public Health Emergency of International Concern (PHEIC). This outbreak known as Bundibugyo virus disease (BVD), a rare, severe, and potentially life-threating viral hemorrhagic fever caused by the Bundibugyo strain of Ebola virus. According to the Uganda Ministry of Health report, the focal origin of the 2026 BVD epidemic was from a male patient who traveled from DRC to Uganda in May 2026, and was admitted to a private hospital in Kampala with severe vomiting, diarrhea, epigastric pain, and weakness. His condition deteriorated with severe wide blood clotting and multi-organ failure and died within 4 days after admittance. Blood and tissue sample testing indicated the presence of the new Bundibugyo virus variant, which is now in active transmission.

2026 BVD Outbreak

First detected in 1976, in DRC and Sudan, Ebola outbreaks are sporadic and arise periodically in far-flung villages across Central and Western Africa. Commonly referred to as Ebola Virus Disease (EVD) with fatality rate of 90% if it goes untreated is considered by global public health agencies as the most-high consequence public health hazard. Fortunately, Ebola threat at the global level is rated as high-consequence but low-risk, appearing sporadically and remained confined to a few remote locations in Africa. Nevertheless, the 2014-2016 outbreak in West Africa was the largest reported Ebola outbreak with more than 28,600 cases reported and more than 11,000 deaths with a few cases spilling to Europe and the United States.

What is unique about the 2026 BVD outbreak? Should the evolving Ebola outbreak trend starting from 1976 to 2026 be a matter of grave global public health concern? Let us briefly review both questions.

To the first question, BVD is a unique viral variant of the Ebola virus as it differs about 32% in its genomic sequence from other ebolavirus variants. Not much is known about this BVD variant of ebolavirus. Notably, Bundibugyo virus was first detected in 2007 in the Bundibugyo district of western Uganda, the 2026 new variant linked to the ongoing outbreak in DRC is a rare strain forming a distinct genomic lineage from other Ebola strains differing by 216-227 nucleotides.

Although this divergence is approximately 1.2 percent from the other common strains, investigators delineate Bundibugyo viral disease (BDV) caused by the Bundibugyo Ebola virus from the Ebola virus disease (EVD) caused by commonly known strains of the virus. This is a key species-level difference that  seem to show major shift in the Ebola outbreak this time around compared to earlier sporadic outbreaks in the region. As a result, public health intervention against BVD is lacking effective diagnostic target choice, vaccine design challenges, and the breadth of current therapeutic medical countermeasures available to public health agencies in the region. This is where the new global health and  health security challenge lies for health agencies in the region and elsewhere.

A key difference between previous Bundibugyo outbreaks and the 2026 outbreak is that the 2007 outbreak had a fatality rate between 30 to 50 percent,which is comparable to the disease caused by other commonly known Ebola virus, the case fatality rate of the ongoing outbreak is slightly higher at 60%. Detailed phylogenetic and molecular analysis of the 2026 BVD variant indicated that the Ebola virus variant causing BVD now in active transmission in DRC and Uganda is a novel variant of natural origin and not a laboratory-derived viral construct as it appears in the case of SARS-CoV-2 virus tied to COVID-19 pandemic. With a slight, but significant, divergence from other BVD Ebola virus variants collected from 2007 to the present, the 2026 BVD is a novel variant with a slightly higher hazard profile, higher pathogenicity, and transmissibility.

As to the second question why the 2026 BVD epidemic cannot be relegated to the backburners of emergency response? WHO procedure for declaring a public health emergency of International Concern  (PHEIC) is the first convene an Emergency Committee for the Ebola outbreak (BVD). This time around WHO took an unusual approach to declare the 2026 BVD outbreak a PHEIC underscoring the seriousness of the current Ebola virus disease outbreak. This might be in part due to scarce public health emergency interventional resources in the affected areas, the highly hazardous nature of the virus together with complete absence of medical countermeasures to combat the outbreak.

According to the latest WHO report BVD Ebola outbreak in DRC is in a phase of intense transmission, having expanded to 54 health zones across six provinces with nearly 5,000 reported cases. The number of actual cases are likely to be higher than the officially reported figures, given the vast geography and distant villages deep within the dense tropical forests. According to official DRC reports, the number of confirmed BVD cases stands at 1,003 and 254 cumulative deaths, which I believe is an underestimate of both the number of cases and fatality. With no licensed vaccine or therapeutics currently available to manage and treat BVD, public health agencies are faced with a serious epidemic in the making.

The 2026 BVD outbreak is unique, in that it has expanded rapidly compared to the historical outbreak of Ebola in the region where remote clusters of cases are reported on a sporadic basis. In contrast, the 2026 BVD outbreak has expanded rapidly with a recent report of more than 3,260 confirmed cases and over 1,430 reported deaths in DRC alone and additional cases reported in Uganda, making this one of the largest Ebola virus diseases in the record, compared to the 2014-16 outbreak in West Africa and 2018-20 outbreak in DRC.

Given the current active transmission of BVD, public health authorities from the region and multilateral agencies are updating the number of reported cases and case fatalities. For instance, as of this writing, the European Center for Disease Prevention and Control reports total confirmed BVD cases at 5,735 and total fatalities at 2,746, which tantamount to a case fatality rate of 47.5%, a much higher fatality rate compared to earlier reports from DRC and Uganda. A total of 770 patients is currently in isolation and under clinical monitoring, which is likely to increase the case fatality rate.

Although US Centers for Disease Control and Prevention declared there are no reported cases of Ebola in the US, the European CDC in its August 2026 status update reported an imported case where a of US citizen evacuated, in May 2026, to Germany for treatment. A similar case was reported, in June 2026, by the Ministry of Health, France.

On 10 July 2026,  US CDC reported of a US citizen working for a humanitarian organization in DRC contracted BVD and the patent was transferred to Germany for medical treatment and surveillance.

Ongoing BVD outbreak caused by a novel variant of Ebola has remained confined for the most part within the geographic boundaries of DRC and Uganda, with a few spillover cases reported in Europe and the US. It is worrisome that the new variants in transmission are slightly more pathogenic and higher fatality ratio. A realistic worst-case scenario poses the  risk of new variants of highly dangerous Ebola virus showing up with a higher propensity for causing the disease and ease of transmission.

The economic costs of 2026 BVD outbreak are real with the recent United Nations Development Program (UNDP) report estimates the damage to the local economies could be as high as $3.6 billion due to travel restrictions and quarantine that prevents locals’ ability to work and sustain the local businesses. UNDP estimates economic adverse impact may lead to nearly a 1 million individuals living in poverty  and contribute to an additional 2,500 plus infant deaths.

With COVID-19 pandemic now in the global public health’s rare mirror, it is easy to disregard the 2026 BVD outbreak merely as sporadic cyclical event. We would be doing so risking a potentially disastrous future global pandemic.